INSM (STOCKS)
Insmed, Inc.
$98.200000
+0.350000 (+0.36%)
Prev close: $97.850000
Company Information
- Exchange
- XNAS
- Sector
- Health Technology
- Industry
- Pharmaceuticals: Major
- CEO
- William H. Lewis
- Asset Type
- stocks
- Website
- Visit
Fundamentals
- Market Cap
- $21,124.69M
- Employees
- 1,271
- P/E (TTM)
- -16.97
- P/B (TTM)
- 30.06
- Dividend Yield
- —
Technical Indicators
- SMA 10
- —
- SMA 20
- —
- SMA 50
- —
- EMA 9
- —
- EMA 21
- —
- RSI
- —
- MACD State
- —
Recent News
No recent news found for this ticker.
Financial Statements
| Revenues | $819.56M |
| Benefits Costs and Expenses | $2.00B |
| Cost Of Revenue | $149.08M |
| Costs And Expenses | $1.97B |
| Gross Profit | $670.48M |
| Operating Expenses | $1.82B |
| Selling, General, and Administrative Expenses | $800.88M |
| Research and Development | $828.00M |
| Operating Income/Loss | -$1.15B |
| Income/Loss From Continuing Operations After Tax | -$1.18B |
| Income/Loss From Continuing Operations Before Tax | -$1.18B |
| Income Tax Expense/Benefit | $5.58M |
| Income Tax Expense/Benefit, Deferred | -$27.00K |
| Net Income/Loss | -$1.18B |
| Net Income/Loss Attributable To Noncontrolling Interest | $0.00 |
| Net Income/Loss Attributable To Parent | -$1.18B |
| Net Income/Loss Available To Common Stockholders, Basic | -$1.18B |
| Participating Securities, Distributed And Undistributed Earnings/Loss, Basic | $0.00 |
| Preferred Stock Dividends And Other Adjustments | $0.00 |
| Basic Earnings Per Share | -$5.74 |
| Diluted Earnings Per Share | -$5.74 |
| Basic Average Shares | 621,456,000 |
| Diluted Average Shares | 621,456,000 |
| Assets | $2.08B |
| Current Assets | $1.61B |
| Inventory | $132.91M |
| Other Current Assets | $1.48B |
| Noncurrent Assets | $462.69M |
| Fixed Assets | $102.85M |
| Other Non-current Assets | $359.84M |
| Liabilities | $1.37B |
| Current Liabilities | $361.01M |
| Accounts Payable | $73.38M |
| Wages | $45.98M |
| Other Current Liabilities | $241.65M |
| Noncurrent Liabilities | $1.01B |
| Long-term Debt | $546.77M |
| Other Non-current Liabilities | $463.23M |
| Equity | $704.85M |
| Equity Attributable To Noncontrolling Interest | $0.00 |
| Equity Attributable To Parent | $704.85M |
| Liabilities And Equity | $2.08B |
| Net Cash Flow From Operating Activities | -$895.66M |
| Net Cash Flow From Operating Activities, Continuing | -$895.66M |
| Net Cash Flow From Investing Activities | $120.53M |
| Net Cash Flow From Investing Activities, Continuing | $120.53M |
| Net Cash Flow From Financing Activities | $954.59M |
| Net Cash Flow From Financing Activities, Continuing | $954.59M |
| Exchange Gains/Losses | -$517.00K |
| Net Cash Flow | $178.94M |
| Net Cash Flow, Continuing | $179.46M |
| Comprehensive Income/Loss | -$1.18B |
| Comprehensive Income/Loss Attributable To Noncontrolling Interest | $0.00 |
| Comprehensive Income/Loss Attributable To Parent | -$1.18B |
| Other Comprehensive Income/Loss | -$1.18B |
| Other Comprehensive Income/Loss Attributable To Parent | $906.00K |